and ________, as Warrant AgentPreferred Stock Warrant Agreement • April 24th, 2019 • Flex Pharma, Inc. • Pharmaceutical preparations • New York
This Preferred Stock Warrant Agreement (this “Agreement”), dated as of between Flex Pharma, Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
and ________, As Warrant AgentCommon Stock Warrant Agreement • April 24th, 2019 • Flex Pharma, Inc. • Pharmaceutical preparations • New York
between Flex Pharma, Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
and ________, as Warrant AgentWarrant Agreement • April 24th, 2019 • Flex Pharma, Inc. • Pharmaceutical preparations • New York
This Debt Securities Warrant Agreement (this “Agreement”), dated as of between Flex Pharma, Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
FLEX PHARMA, INC., Issuer AND [TRUSTEE], TrusteeIndenture • April 24th, 2019 • Flex Pharma, Inc. • Pharmaceutical preparations • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
